Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. Additionally we are shipping Lymphocyte-Activation Gene 3 Proteins (28) and Lymphocyte-Activation Gene 3 Kits (14) and many more products for this protein.
Showing 10 out of 217 products:
Human Monoclonal LAG3 Primary Antibody for FACS - ABIN4329756
Demeure, Wolfers, Martin-Garcia, Gaulard, Triebel: T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts. in European journal of cancer (Oxford, England : 1990) 2001
Show all 9 references for ABIN4329756
Human Monoclonal LAG3 Primary Antibody for FACS, ICC - ABIN4329753
Casati, Camisaschi, Novellino, Mazzocchi, Triebel, Rivoltini, Parmiani, Castelli: Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation. in Journal of immunology (Baltimore, Md. : 1950) 2008
Show all 9 references for ABIN4329753
Human Polyclonal LAG3 Primary Antibody for FACS - ABIN4896615
Melve, Ersvaer, Akkök, Ahmed, Kristoffersen, Hervig, Bruserud: Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor. in International journal of molecular sciences 2016
Show all 5 references for ABIN4896615
Mouse (Murine) Monoclonal LAG3 Primary Antibody for FACS - ABIN120324
Workman, Rice, Dugger, Kurschner, Vignali: Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3). in European journal of immunology 2002
Show all 2 references for ABIN120324
Mouse (Murine) Monoclonal LAG3 Primary Antibody for FACS - ABIN120325
Workman, Vignali: Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). in Journal of immunology (Baltimore, Md. : 1950) 2005
Show all 2 references for ABIN120325
Human Polyclonal LAG3 Primary Antibody for FACS, WB - ABIN4899755
Illingworth, Butler, Roetynck, Mwacharo, Pierce, Bejon, Crompton, Marsh, Ndungu: Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. in Journal of immunology (Baltimore, Md. : 1950) 2013
Human Monoclonal LAG3 Primary Antibody for FACS - ABIN4896610
Kong, Zhang, Claxton, Ehmann, Rybka, Zhu, Zeng, Schell, Zheng: PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation. in Blood cancer journal 2015
Human Polyclonal LAG3 Primary Antibody for FACS, IF (cc) - ABIN748508
Parodi, Battaglia, Kalli, Ferrera, Conteduca, Tardito, Stringara, Ivaldi, Negrini, Borgonovo, Simonato, Traverso, Carmignani, Fenoglio, Filaci: CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes. in Cancer immunology, immunotherapy : CII 2013
We show that the expression of LAG3 is highly induced in the lungs and particularly in the granulomatous lesions of macaques experimentally infected with mycobacterium tuberculosis.
Study suggests that expression of the inhibitory receptors PD-1 (show PDCD1 Antibodies) and LAG-3 on CD4 (show CD4 Antibodies)(+) T cells and their reduced IL-2 (show IL2 Antibodies) production are common characteristic features of Plasmodium infection.
An IL-27 (show IL27 Antibodies)/Lag3 axis enhances Foxp3 (show FOXP3 Antibodies)+ regulatory T cell-suppressive function and therapeutic efficacy.
LAG3 and PD1 (show PDCD1 Antibodies) co-inhibitory molecules have roles in collaborating to limit CD8 (show CD8A Antibodies)+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
Poxvirus-Based Active Immunotherapy with PD-1 (show PDCD1 Antibodies) and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice.
Lymphatic endothelial cells (LECs) serve as an antigen reservoir for CD4 (show CD4 Antibodies) T-cell tolerance, and MHC-II molecules on LECs are used to induce CD8 (show CD8A Antibodies) T-cell tolerance via LAG-3.
LAG-3 expression on Tconv cells makes them more susceptible to Treg based suppression, and also regulates the development of a TH1 (show HAND1 Antibodies) T-cell response.
LAG-3 exerts an important regulatory effect on autoimmunity.
Lag-3 is an important regulatory molecule involved in alloreactive T cell proliferation and activation after bone marrow transplantation.
these results define a strong synergy between the PD-1 (show PDCD1 Antibodies) and LAG-3 inhibitory pathways in tolerance to both self and tumor antigens.
We conclude that LAG-3 is necessary for regulating CD4 (show CD4 Antibodies)(+) and CD8 (show CD8A Antibodies)(+) T cell function during autoimmune diabetes
LAG-3 is highly expressed in peripheral blood CD8 (show CD8A Antibodies)+ T cells in chronic HBV-infected patients.
Data indicate that in recurrent spontaneous abortion patients, the expression levels of CD49b (show ITGA2 Antibodies) and LAG-3 (CD223) on CD14 (show NDUFA2 Antibodies)(+) mononuclear cells and the plasma level of transforming growth factor beta (TGF-beta) decreased obviously compared with normal females.
iNKT cytokine production is profoundly altered by both HIV infection and treatment, and LAG-3, but not PD-1 (show PDCD1 Antibodies), expression is associated with a reduction in iNKT IFNgamma production.
NFKB1 (show NFKB1 Antibodies), CD27 (show CD27 Antibodies), LAG3 and IKZF3 (show IKZF3 Antibodies) are new susceptibility genes for psoriasis.
The elevated expression of LAG-3 at the genital tract suggests it may regulate T-cell activation, and identify cells susceptible to HIV infection. The enrichment of LAG-3 on double negative T cells suggests LAG-3 may contribute to the immunoregulatory activity of these cells.
the LAG-3/MHC class II (show HLA-DPA1 Antibodies) pathway may synergize with PD-1 (show PDCD1 Antibodies)/PD ligand to enhance T cell-mediated immune responses.
LAG-3 trafficking from lysosomal compartments to the cell surface is dependent on the cytoplasmic domain through protein kinase C (show PKC Antibodies) signaling in activated T cells.
These results suggest that LAG-3-mediated activation of plasmacytoid dendritic cells takes place in vivo at tumor sites, and it is in part responsible for directing an immune-suppressive environment.
Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8 (show CD8A Antibodies)(+) T cell in HCC (show FAM126A Antibodies) patients.
Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4.
lymphocyte-activation gene 3
, lymphocyte-activation protein 3
, lymphocyte-activation protein 3-like
, lymphocyte activation gene 3 protein-like
, lymphocyte activation gene 3 protein
, lymphocyte activation gene 3